Contraceptive News and Research

RSS

Over 44% of internet Viagra is counterfeit

Research by UK, Swedish and American researchers shows that taking internet drugs can kill and bypassing health systems can leave life-threatening problems undiagnosed. It's estimated that 90% of counterfeit drugs are sold on the internet, 44% of internet Viagra is fake, the global sale of counterfeit drugs will reach $75 billion this year and EU seizures have risen dramatically. Counterfeit drug deaths include men who took fake erectile dysfunction drugs, pregnant women injected with fake iron for anaemia and children who took paracetamol syrup contaminated with antifreeze.

20 Jan 2010

UNAIDS chief calls for reduction in MTCT in Africa

UNAIDS Executive Director Michel Sidibe on Monday during a five-day trip in Kenya, called for a drastic reduction in mother-to-child transmission (MTCT) of HIV in sub-Saharan Africa, Capital News reports. "In our continent we still have 400,000 babies born every year with HIV and we know if we are capable of making sure that testing will become available universally to all our pregnant women, (and) that pregnant women also have access to treatment, we will prevent the transmission," Sidibe said (Karong'o, 1/11).

13 Jan 2010

Salt Lake City research center joins international drug trial program for painful menstrual cramps

A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating and psychologically taxing and is one of the leading causes of absenteeism from work and school.

12 Jan 2010

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

A leading clinical research center in Austin has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States.

12 Jan 2010

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Antares Pharma, Inc. and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing the Antares ATD (advanced transdermal delivery) gel system. Based on this successful data, the two parties continue to expect to partner with a worldwide or regional pharmaceutical company in order to commercialize this novel contraceptive gel.

12 Jan 2010

Obama administration supports Cairo conference goals, Clinton says

Secretary of State Hillary Rodham Clinton on Friday "reiterated the Obama administration's support" for universal access to family planning, improving maternal health care and other goals outlined at the 1995 International Conference on Population and Development Action Plan held in Cairo, Egypt, All Headline News reports.

12 Jan 2010

Health and development groups applaud Clinton speech; call for action

A broad coalition of organizations representing millions of Americans applauded today's statement by Secretary of State Hillary Clinton that the United States unequivocally supports the worldwide consensus that achieving universal access to reproductive health is critical for individual health, family well-being, broader economic development and a healthy planet.

9 Jan 2010

Watson Pharmaceuticals files ANDA with FDA seeking approval to market LoSeasonique

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.10 mg/0.02 mg) oral contraceptive product prior to the expiration of U.S. Patent No. 7,615,545, which is owned by Duramed Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceutical Industries, Ltd.

9 Jan 2010

Discovery of inhibitory hormone may yield new treatments for cancer and other diseases

Nearly 10 years after the discovery that birds make a hormone that suppresses reproduction, University of California, Berkeley, neuroscientists have established that humans make it too, opening the door to development of a new class of contraceptive and possible treatments for cancer or other diseases.

23 Dec 2009

Women using DMPA experience high BMD loss, researchers say

Nearly half of women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, will experience high bone mineral density (BMD) loss in the hip or lower spine within two years of beginning the contraceptive, according to researchers at the University of Texas Medical Branch at Galveston.

22 Dec 2009

Gynaecological visits presents great opportunities for dialogue about sexual health

Visits to a gynaecologist or midwife are generally associated with different tests and/or prescriptions for contraceptives, but could offer so much more. Women, doctors and midwives are agreed that gynaecological visits presents great opportunities for dialogue about sexual health, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

16 Dec 2009

U.S. patent for new bioadhesive drug delivery system awarded to SRI International

SRI International, an independent nonprofit research and development organization, announced today the award of U.S. patent 7,592,021 for a new bioadhesive drug delivery system that enables enhanced release of drugs through the human body's mucous membranes.

16 Dec 2009

Teens, contraception and unplanned pregnancy

Nearly all unmarried young adults ages 18-29 believe pregnancy is something that should be planned (94% of men and 86% of women) and say that it is important to avoid pregnancy in their lives right now (86% of men and 88% of women), according to new research released by The National Campaign to Prevent Teen and Unplanned Pregnancy.

15 Dec 2009

Catholics for Choice's statement on restriction of abortion coverage

"Today, Senator Ben Nelson (D-Nebraska) put the policy priorities of the U.S. Catholic bishops before the needs of women nationwide. Originally, Senator Nelson maintained that the abortion language in the healthcare bill was not a make-or-break factor in his vote.

8 Dec 2009

Doubling of global investments in family planning, birth control could cut maternal, newborn deaths, report says

By doubling investments in family planning and birth control, developing countries could nearly halve newborn deaths and reduce maternal deaths by 70 percent, a new report said Thursday, Reuters reports.

4 Dec 2009

Health Policy Research Roundup

UCLA Center For Health Policy Research: Health Disparities Among California's Nearly Four Million Low-Income Nonelderly Adult Women - Using data from the 2007 California Health Interview Survey, the authors of this policy brief compare low-income women, ages 18-64, to others. The report finds the low-income women are four times more likely to report fair or poor health and are more likely to report a health condition that interferes with basic physical activities, such as walking or climbing stairs.

4 Dec 2009

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur more often in people who said they had been diagnosed with epilepsy versus those without an epilepsy diagnosis, according to a survey of approximately 173,000 households across the U.S.

4 Dec 2009

Reproductive Health Matters' November issue focuses on criminalisation

Elsevier announced today the publication of the November issue of Reproductive Health Matters. Articles in the issue look at criminalisation in relation to a range of global issues: rape and sexual violence; female genital mutilation; selling and buying sex; provision and use of modern contraception and induced abortion; homosexuality, and HIV transmission.

4 Dec 2009

More investment in family planning and pregnancy-related care will reduce maternal and newborn deaths

Maternal deaths in developing countries could be slashed by 70% and newborn deaths cut nearly in half if the world doubled investment in family planning and pregnancy-related care, shows a new report by the Guttmacher Institute and UNFPA, the United Nations Population Fund. Currently, more than half a million maternal deaths and 3.5 million newborn deaths, many of them easily preventable, occur each year in developing countries.

4 Dec 2009

Bishop-endorsed healthcare system can undermine medical treatments and preventative measures

If the Catholic bishops have their way, many medical treatments and preventative measures we take for granted may be under threat. The pressure that the US bishops have brought to bear on the debate over healthcare reform has been widely reported.

3 Dec 2009

Contraceptive News and Research

Over 44% of internet Viagra is counterfeit

UNAIDS chief calls for reduction in MTCT in Africa

Salt Lake City research center joins international drug trial program for painful menstrual cramps

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Obama administration supports Cairo conference goals, Clinton says

Health and development groups applaud Clinton speech; call for action

Watson Pharmaceuticals files ANDA with FDA seeking approval to market LoSeasonique

Discovery of inhibitory hormone may yield new treatments for cancer and other diseases

Women using DMPA experience high BMD loss, researchers say

Gynaecological visits presents great opportunities for dialogue about sexual health

U.S. patent for new bioadhesive drug delivery system awarded to SRI International

Teens, contraception and unplanned pregnancy

Catholics for Choice's statement on restriction of abortion coverage

Doubling of global investments in family planning, birth control could cut maternal, newborn deaths, report says

Health Policy Research Roundup

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Reproductive Health Matters' November issue focuses on criminalisation

More investment in family planning and pregnancy-related care will reduce maternal and newborn deaths

Bishop-endorsed healthcare system can undermine medical treatments and preventative measures

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News